Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18373853 | 0.87 | — | — | |
| SCHEMBL28488917 | 0.86 | SHBG (0.43) | SHBGEPHX1CYP1A2 | |
| SCHEMBL7888229 | 0.84 | SHBG (0.39) | SHBGCYP1A2 | |
| SCHEMBL8775662 | 0.83 | SHBG (0.40) | SHBGEPHX1CYP1A2MAPT | |
| SCHEMBL29098458 | 0.80 | SHBG (0.56) | SHBGEPHX1SMN1; SMN2CYP1A2TP53 | |
| Dimethylamine SCHEMBL9836630 | 0.78 | SIGMAR1 (0.39) | EPHX1 | |
| SCHEMBL23522672 | 0.75 | SHBG (0.50) | SHBGEPHX1SMN1; SMN2CYP1A2TP53 | |
| SCHEMBL3037218 | 0.75 | EPHX1 (0.50) | SHBGEPHX1SMN1; SMN2CYP1A2TP53 | |
| SCHEMBL10582810 | 0.75 | EPHX1 (0.50) | SHBGEPHX1SMN1; SMN2CYP1A2TP53 | |
| SCHEMBL24319748 | 0.74 | SHBG (0.61) | SHBGEPHX1SMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993018748-A1 | COMPOSITIONS COMPRISING A DRUG DELIVERY VEHICLE SUSPENDED IN A NONAQUEOUS FLUORINATED LIQUID | ALLERGAN, INC. (US) | 1993-09-30 | — | — | WO | claimed |
| EP-1648923-B1 | SPATIALLY-DEFINED MACROCYCLES INCORPORATING PEPTIDE BOND SURROGATES | TRANZYME PHARMA INC (CA) | 2008-12-31 | — | — | EP | disclosed |
| EP-0794801-A1 | PARAMAGNETIC COMPLEXES OF N-ALKYL-N-HYDROXYLAMIDES OF ORGANIC ACIDS AND EMULSIONS CONTAINING SAME FOR MAGNETIC RESONANCE IMAGING (MRI) | HEMAGEN/PFC (US) | 1997-09-17 | — | — | EP | disclosed |
| WO-1996016679-A1 | PARAMAGNETIC COMPLEXES OF N-ALKYL-N-HYDROXYLAMIDES OF ORGANIC ACIDS AND EMULSIONS CONTAINING SAME FOR MAGNETIC RESONANCE IMAGING (MRI) | HEMAGEN/PFC (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1995033494-A1 | EMULSIONS OF PARAMAGNETIC CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING (MRI), CONTAINING AN ORGANIC CHELATOR HAVING AN UNSATURATED ALIPHATIC GROUP | HEMAGEN/PFC (US) | 1995-12-14 | — | — | WO | disclosed |
| WO-1994014415-A1 | FLUOROCARBON EMULSIONS | HEMAGEN/PFC (US) | 1994-07-07 | — | — | WO | disclosed |
| WO-1983003201-A1 | METHODS OF TREATING THE EYE WITH LIQUID PERFLUOROCARBONS | CHILDRENS HOSP MEDICAL CENTER (US) | 1983-09-29 | — | — | WO | disclosed |
| EP-0033402-B1 | PERFUSATE FOR PRESERVING ORGAN TO BE TRANSPLANTED AND PRESERVING METHOD | The Green Cross Corporation (JP) | 1983-09-07 | — | — | EP | disclosed |